Large Wilshire Enterprises (WOC) Plans Fight Unless The Board Eliminates or Raises the Poison Pill Threshold

In an amended 13D filing on Wilshire Enterprises (AMEX: WOC), 14.87% holder, Bulldog Investors/ Phillip Goldstein/Andrew Dakos disclosed a letter sent to the company saying unless the board acts by December 5th to either eliminate or raise the threshold of the poison pill to 21%, they intend to (1) present a proposal at the next shareholder meeting to eliminate the poison pill and to elect directors that will support that proposal; and (2) commence litigation to eliminate the poison pill.

A Copy of the Letter:

Dear Ms. Wilzig Izak:

As you know, Full Value Partners L.P. is a member of a group that owns almost 15% of the outstanding common stockof Wilshire Enterprises, Inc. ("WOC") and is its largest outside shareholder.

When we met on September 26, 2006 I requested that the board either eliminate or raise the threshold of WOC's poison pill. In general, we believe that poison pills act to insulate and entrench incumbent boards and managements thereby making them less accountable to shareholders. The situation at WOC is particularly disturbing in that your father's estate owns over 21%of WOC stock, well in excess of the 15% threshold at which the poison pill would be triggered by any other shareholder.

During a subsequent telephone call we again asked youto recommend that the board eliminate or raise the threshold of the poison pill. We have yet to get a response.

Our patience is not boundless. Therefore, we have decided that unless the board acts by December 5, 2006t o eliminate or lift the threshold for WOC's poison pill to 21%, we intend to (1) present a proposal at the next shareholder meeting to eliminate the poison pill and to elect directors that will support that proposal; and(2) commence litigation to eliminate the poison pill.

It is unfortunate that one result of these actions will be that WOC will incur costs it can ill afford given its tiny size. But what choice do we have given your failure to respond to our previous requests to address our concerns?

Very truly yours,

Andrew Dakos

Managing Member

Full Value Advisors LLP

General Partner